BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4120025)

  • 21. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
    De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
    Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleomycin and pulmonary screening: many questions, few answers.
    Duncan CN
    Pediatr Blood Cancer; 2014 Sep; 61(9):1527-8. PubMed ID: 24810221
    [No Abstract]   [Full Text] [Related]  

  • 23. Collision of squamous-cell carcinoma with melanoma in situ in a child with xeroderma pigmentosum.
    Hofer A; Kaddu S; Seidl H; Kerl H; Wolf P
    Dermatology; 2001; 203(1):66-9. PubMed ID: 11549805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials with bleomycin in lymphomas and in solid tumors.
    Bonadonna G; De Lena M; Monfardini S; Bartoli C; Bajetta E; Beretta G; Fossati-Bellani F
    Eur J Cancer (1965); 1972 Apr; 8(2):205-15. PubMed ID: 4116302
    [No Abstract]   [Full Text] [Related]  

  • 25. Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.
    Mosher MB; DeConti RC; Bertino JR
    Cancer; 1972 Jul; 30(1):56-60. PubMed ID: 4114341
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.
    Ameri AH; Mooradian MJ; Emerick KS; Park JC; Wirth LJ; Asgari MM; Tsao H; Lawrence D; Sullivan RJ; Demehri S
    Br J Dermatol; 2019 Nov; 181(5):1095-1097. PubMed ID: 31102460
    [No Abstract]   [Full Text] [Related]  

  • 27. Jumping end-to-end dicentrics in a case of squamous cell carcinoma from a patient with xeroderma pigmentosum.
    Aledo R; Aurias A; Avril MF; Dutrillaux B
    Cancer Genet Cytogenet; 1989 Jul; 40(1):95-103. PubMed ID: 2758404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two familial cases of xeroderma pigmentosum].
    Constantinidès G; Huriez C; Hochart G; Dhoine G
    Bull Mem Soc Fr Ophtalmol; 1976; 88():242-4. PubMed ID: 1029608
    [No Abstract]   [Full Text] [Related]  

  • 29. Interstitial pneumonitis associated with bleomycin therapy.
    Luna MA; Bedrossian CW; Lichtiger B; Salem PA
    Am J Clin Pathol; 1972 Nov; 58(5):501-10. PubMed ID: 4118423
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
    Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bleomycin, a new antitumour antibiotic in the treatment of neoplastic diseases].
    Christensen L
    Wien Klin Wochenschr; 1972 Nov; 84(46):737-43. PubMed ID: 4117777
    [No Abstract]   [Full Text] [Related]  

  • 32. Dramatic response to nivolumab in xeroderma pigmentosum skin tumor.
    Chambon F; Osdoit S; Bagny K; Moro A; Nguyen J; Réguerre Y
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
    Gleason MC
    Plast Reconstr Surg; 1970 Dec; 46(6):577-81. PubMed ID: 4923952
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spinocellular carcinoma of the upper lip in a child with Xeroderma pigmentosum].
    Perrotta R; Tarico MS; Pompili G; Camilleri V
    Pediatr Med Chir; 2009; 31(3):126-9. PubMed ID: 19739492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary histopathological changes in subjects with malignant tumors treated with bleomycin].
    Rilke F; Pilotti S
    Tumori; 1971; 57(4):287-96. PubMed ID: 4111184
    [No Abstract]   [Full Text] [Related]  

  • 36. Bleomycin: pulmonary toxicity.
    Rudders RA
    Ann Intern Med; 1973 Apr; 78(4):618. PubMed ID: 4121001
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids.
    Al-Salem T; Ali ZS; Qassab M
    Lancet; 1980 Aug; 2(8188):264-5. PubMed ID: 6105418
    [No Abstract]   [Full Text] [Related]  

  • 38. A clinical review of bleomycin--a new antineoplastic agent.
    Blum RH; Carter SK; Agre K
    Cancer; 1973 Apr; 31(4):903-14. PubMed ID: 4122362
    [No Abstract]   [Full Text] [Related]  

  • 39. Bleomycin and pulmonary toxicity.
    Van Barneveld PW; Mulder NH; Van der Mark TW; Sleijfer DT
    Neth J Med; 1985; 28(11):516-23. PubMed ID: 2417127
    [No Abstract]   [Full Text] [Related]  

  • 40. Retinoids in the management of non-melanoma skin cancer and melanoma.
    Craven NM; Griffiths CE
    Cancer Surv; 1996; 26():267-88. PubMed ID: 8783579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.